explore -WSS

explore

author：explore 2025-09-30 09:57:16 - browse：82

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： New menopause drug shows promise in relief for hot flashes

entertainment

WSS

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

New Medicare drug pricing powers could soon be upended in court

Designating disabled people as health disparity population is crucial

DeSantis can now import cheaper drugs. But will Biden get credit?

hotspot

explore

hotspot

Medical records are filled with copy

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Dobbs anniversary: the lost opportunity of abortion as health care

Flash flood warnings continue for parts of Missouri, Illinois

Affirmative action in medical school literally saved lives

Risky weight loss products often used by teens globally, per study

How one medical school became remarkably diverse

Failure, not just success, should guide future doctors

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

HHS names first

hotspot

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Risky weight loss products often used by teens globally, per study

Sage considers ways to reduce costs following FDA rejection

New Medicare drug pricing powers could soon be upended in court

Judge in Trump's classified documents case questions use of out

Doctors are clamoring for more clarity on Paxlovid prescribing

entertainment

explore

hotspot

Wikipedia